Hussman Strategic Advisors, Inc. Incyte Corp Transaction History
Hussman Strategic Advisors, Inc.
- $417 Million
- Q1 2024
A detailed history of Hussman Strategic Advisors, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 31,500 shares of INCY stock, worth $1.82 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
31,500
Previous 31,500
-0.0%
Holding current value
$1.82 Million
Previous $1.98 Million
9.26%
% of portfolio
0.43%
Previous 0.45%
Shares
5 transactions
Others Institutions Holding INCY
# of Institutions
618Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.09 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.34 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.31 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$889 Million0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$571 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $12.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...